The current understanding on the impact of KRAS on colorectal cancer - ScienceDirect
Immune modulatory effects of oncogenic KRAS in cancer | Nature Communications
The Trouble With KRAS - Cancer Commons
The improbable targeted therapy: KRAS as an emerging target in non-small cell lung cancer (NSCLC) - ScienceDirect
Overcoming KRAS-Mutant Lung Cancer | American Society of Clinical Oncology Educational Book
KRAS(G12D) can be targeted by potent inhibitors via formation of salt bridge | Cell Discovery
Yap1 Activation Enables Bypass of Oncogenic Kras Addiction in Pancreatic Cancer: Cell
Molecular epidemiology and diagnostics of KRAS mutations in human cancer | SpringerLink
Combination of KRAS gene silencing and PI3K inhibition for ovarian cancer treatment - ScienceDirect
Frontiers | Targeting KRAS in Lung Cancer Beyond KRAS G12C Inhibitors: The Immune Regulatory Role of KRAS and Novel Therapeutic Strategies
KRAS drives immune evasion in a genetic model of pancreatic cancer | Nature Communications
KRAS Screening & Profiling
Integrated multi-omics characterization of KRAS mutant colorectal cancer
A): Dynamic change in tumor marker (CA125) (blue line) and KRAS G12V... | Download Scientific Diagram
KRAS Mutation in Colon Cancer: A Marker of Resistance to EGFR-I Therapy | SpringerLink
An integrative pharmacogenomics analysis identifies therapeutic targets in KRAS-mutant lung cancer - eBioMedicine
KRAS Mutations as Prognostic and Predictive Markers in Non–Small Cell Lung Cancer - ScienceDirect
Cancers | Free Full-Text | KRAS in NSCLC: State of the Art and Future Perspectives
Frontiers | Targeting KRAS: The Elephant in the Room of Epithelial Cancers
Hitting an Elusive Target in Pancreatic Cancer - NCI
Differential Reprogramming of Isogenic Colorectal Cancer Cells by Distinct Activating KRAS Mutations | Journal of Proteome Research
Frontiers | New Horizons in KRAS-Mutant Lung Cancer: Dawn After Darkness
IJMS | Free Full-Text | KRAS-Mutant Non-Small-Cell Lung Cancer: From Past Efforts to Future Challenges
Chemically modified MIR143-3p exhibited anti-cancer effects by impairing the KRAS network in colorectal cancer cells: Molecular Therapy - Nucleic Acids
Frontiers | Targeting KRAS Mutant in Non-Small Cell Lung Cancer: Novel Insights Into Therapeutic Strategies
